Ingrid Delaet Neurocrine Biosciences Inc (NBIX) insider trading activity

Ingrid Delaet is Chief Regulatory Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 7,507 shares of NBIX, which is worth approximately $1.02 Million. The most recent transaction as insider was on May 06, 2024, when has been sold 273 shares (Common Stock) at a price of $140.55 per share, resulting in proceeds of $38,370. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.51K

0% 3M change

n/a 12M change

Total Value Held $1.02 Million

Ingrid Delaet Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 06 2024	SELL Open market or private sale	$38,370 $140.55 p/Share	273 Reduced 3.51%	7,507 Common Stock
May 06 2024	BUY Exercise of conversion of derivative security	$21,572 $79.02 p/Share	273 Added 3.39%	7,780 Common Stock
Apr 01 2024	SELL Open market or private sale	$37,345 $137.3 p/Share	272 Reduced 3.5%	7,507 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$21,493 $79.02 p/Share	272 Added 3.38%	7,779 Common Stock
Mar 21 2024	SELL Open market or private sale	$725,300 $145.06 p/Share	5,000 Reduced 39.98%	7,507 Common Stock
Mar 21 2024	BUY Exercise of conversion of derivative security	$517,600 $103.52 p/Share	5,000 Added 28.56%	12,507 Common Stock
Mar 13 2024	SELL Open market or private sale	$420,419 $140.14 p/Share	3,000 Reduced 28.55%	7,507 Common Stock

Mar 13 2024	BUY Exercise of conversion of derivative security	$318,060 $106.02 p/Share	3,000 Added 22.21%	10,507 Common Stock
Mar 11 2024	SELL Open market or private sale	$28,000 $140.0 p/Share	200 Reduced 2.6%	7,507 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	$21,204 $106.02 p/Share	200 Added 2.53%	7,707 Common Stock
Mar 08 2024	SELL Open market or private sale	$252,054 $140.03 p/Share	1,800 Reduced 19.34%	7,507 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$190,836 $106.02 p/Share	1,800 Added 16.21%	9,307 Common Stock
Feb 29 2024	SELL Open market or private sale	$36,994 $135.51 p/Share	273 Reduced 3.51%	7,507 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	$21,572 $79.02 p/Share	273 Added 3.39%	7,780 Common Stock
Feb 28 2024	SELL Open market or private sale	$886,188 $135.42 p/Share	6,544 Reduced 46.57%	7,507 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	$517,106 $79.02 p/Share	6,544 Added 41.96%	9,051 Common Stock
Feb 13 2024	SELL Open market or private sale	$95,249 $133.03 p/Share	716 Reduced 8.71%	7,507 Common Stock
Feb 01 2024	SELL Open market or private sale	$87,076 $139.77 p/Share	623 Reduced 8.32%	6,865 Common Stock
Jan 31 2024	SELL Open market or private sale	$59,898 $141.94 p/Share	422 Reduced 6.27%	6,309 Common Stock
Aug 28 2023	SELL Open market or private sale	$153,861 $107.52 p/Share	1,431 Reduced 19.44%	5,931 Common Stock
Aug 21 2023	SELL Open market or private sale	$150,817 $107.42 p/Share	1,404 Reduced 23.21%	4,645 Common Stock

Ingrid Delaet

Chief Regulatory Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account